3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum

Adams, 2000, Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum, J. Neurochem., 75, 2061, 10.1046/j.1471-4159.2000.0752061.x Adams, 2001, Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum, Neuroscience, 102, 843, 10.1016/S0306-4522(00)00530-3 Adams, 2003, Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix, J. Neurochem., 84, 87, 10.1046/j.1471-4159.2003.01507.x Alexander, 1989, Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum, Proc. Natl. Acad. Sci., 86, 5202, 10.1073/pnas.86.13.5202 Altar, 1985, Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol, J. Pharmacol. Exp. Ther., 233, 527 Bankson, 2001, 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin–dopamine interactions, J. Pharmacol. Exp. Ther., 297, 846 Benwell, 1993, Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine, Psychopharmacology, 112, 467, 10.1007/BF02244896 Boyson, 1986, Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain, J. Neurosci., 6, 3177, 10.1523/JNEUROSCI.06-11-03177.1986 Callaway, 1991, Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists, Psychopharmacology, 104, 293, 10.1007/BF02246026 Camarero, 2002, Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine (‘Ecstasy’)-induced dopamine release and free radical formation in the mouse striatum, J. Neurochem., 81, 961, 10.1046/j.1471-4159.2002.00879.x Castel, 1994, Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment, Eur. J. Neurosci., 6, 646, 10.1111/j.1460-9568.1994.tb00310.x Castel, 1994, Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat, Eur. J. Pharmacol., 262, 1, 10.1016/0014-2999(94)90021-3 Civelli, 1985, Sequence and expression of the rat prodynorphin gene, Proc. Natl. Acad. Sci. U. S. A., 82, 4291, 10.1073/pnas.82.12.4291 Compan, 1997, Selective effects of partial and severe lesions of the serotonergic systems on met-enkephalin and substance P neurons in rat basal ganglia, Brain Res. Mol. Brain Res., 50, 246, 10.1016/S0169-328X(97)00198-8 Crespi, 1997, Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine, Br. J. Pharmacol., 12, 1735, 10.1038/sj.bjp.0701325 Dewar, 1991, [3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region, Synapse, 9, 14, 10.1002/syn.890090104 Fleckenstein, 1999, Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function, Eur. J. Pharmacol., 382, 45, 10.1016/S0014-2999(99)00588-9 Ginty, 1996, Calcium regulation of gene expression: isn't that spatial?, Neuron, 18, 183, 10.1016/S0896-6273(00)80258-5 Gonzalez-Nicolini, 2002, NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum, Brain Res., 931, 41, 10.1016/S0006-8993(02)02250-3 Gray, 1999, The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum, J. Neurochem., 73, 1066, 10.1046/j.1471-4159.1999.0731066.x Green, 2003, The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”), Pharmacol. Rev., 55, 463, 10.1124/pr.55.3.3 Gresch, 1999, Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease, Neuroscience, 93, 831, 10.1016/S0306-4522(99)00238-9 Gresch, 1999, Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat, Brain Res. Mol. Brain Res., 70, 125, 10.1016/S0169-328X(99)00138-2 Gygi, 1994, Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions, J. Pharmacol. Exp. Ther., 270, 192 Hanson, 1999, Dopamine D-1 regulation of caudate neurotensin mRNA in the presence of absence of the nigrostriatal dopamine pathway, Brain Res. Mol. Brain Res., 66, 111, 10.1016/S0169-328X(99)00033-9 Hurd, 1992, Influence of a single injection of cocaine, amphetamine, or GBR 12909 on mRNA expression of striatal neuropeptides, Brain Res. Mol. Brain Res., 16, 97, 10.1016/0169-328X(92)90198-K Johnson, 1991, Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems, Eur. J. Pharmacol., 193, 367, 10.1016/0014-2999(91)90153-H Keefe, 1996, D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors, J. Comp. Neurol., 367, 165, 10.1002/(SICI)1096-9861(19960401)367:2<165::AID-CNE1>3.0.CO;2-3 Kehne, 1996, Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats, Neuropsychopharmacology, 15, 116, 10.1016/0893-133X(95)00160-F Krause, 1987, Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A, Proc. Natl. Acad. Sci., 84, 881, 10.1073/pnas.84.3.881 Mansour, 1992, A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques, Neuroscience, 46, 959, 10.1016/0306-4522(92)90197-A McCreary, 1999, Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors, J. Pharmacol. Exp. Ther., 290, 965 McGeorge, 1989, The organization of the projection from the cerebral cortex to the striatum in the rat, Neuroscience, 29, 503, 10.1016/0306-4522(89)90128-0 Merchant, 1994, Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects, J. Pharmacol. Exp. Ther., 269, 806 Nash, 1991, Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors, J. Pharmacol. Exp. Ther., 259, 820 Nishijima, 1996, Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo microdialysis, Synapse, 22, 304, 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F Nomikos, 1990, In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis, Synapse, 6, 106, 10.1002/syn.890060113 Parent, 1995, Functional anatomy of the basal ganglia I. The cortico-basal ganglia-thalamo-cortical loop, Brain Res. Rev., 20, 91, 10.1016/0165-0173(94)00007-C Pompei, 2002, Preprotachykinin A gene expression after administration of 3,4-methylenedioxymethamphetamine (Ecstasy), Eur. J. Pharmacol., 450, 245, 10.1016/S0014-2999(02)02158-1 Pompeiano, 1994, Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors, Brain Res. Mol. Brain Res., 23, 163, 10.1016/0169-328X(94)90223-2 Rompre, 2000, Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization, Neuropharmacology, 39, 1880, 10.1016/S0028-3908(99)00269-5 Rudnick, 1992, The molecular mechanism of “Ecstasy” [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release, Proc. Natl. Acad. Sci. U. S. A., 89, 1817, 10.1073/pnas.89.5.1817 Sabol, 1998, Reserpine attenuates d-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis, Brain Res., 806, 69, 10.1016/S0006-8993(98)00720-3 Schmidt, 1994, Blockade of striatal 5-hydroxytryptamine 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4 methylenedioxymethamphetamine, J. Neurochem., 62, 1382, 10.1046/j.1471-4159.1994.62041382.x Skoog, 1986, Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine, Neuropharmacology, 25, 777, 10.1016/0028-3908(86)90095-X Smith, 1994, Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum, Brain Res. Mol. Brain Res., 21, 359, 10.1016/0169-328X(94)90268-2 Soghomonian, 1987, Serotonin innervation in adult rat neostriatum: I. Quantified regional distribution, Brain Res., 425, 85, 10.1016/0006-8993(87)90486-0 Steiner, 1993, Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum, J. Neurosci., 13, 5066, 10.1523/JNEUROSCI.13-12-05066.1993 Tassin, 1976, Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum: I. Microestimation of [3H] dopamine uptake and dopamine content in microdiscs, Brain Res., 107, 291, 10.1016/0006-8993(76)90227-4 Ternaux, 1977, The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat, Brain Res., 121, 311, 10.1016/0006-8993(77)90154-8 Tzaferis, 2001, Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum, Brain Res. Mol. Brain Res., 93, 27, 10.1016/S0169-328X(01)00178-4 Walker, 1991, Serotonin regulation of tachykinin biosynthesis in rat neostriatum, Brain Res., 546, 33, 10.1016/0006-8993(91)91155-T Walker, 1996, Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission, Brain Res., 732, 25, 10.1016/0006-8993(96)00483-0 Wall, 1995, Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux, Mol. Pharmacol., 47, 544 Wang, 1995, Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain, J. Pharmacol. Exp. Ther., 273, 909 Wang, 1996, D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine, Synapse, 22, 114, 10.1002/(SICI)1098-2396(199602)22:2<114::AID-SYN4>3.0.CO;2-G Ward, 1996, Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum, J. Comp. Neurol., 370, 405, 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R Widmann, 1996, Topographical distribution of amines and major amine metabolites in the rat striatum, Brain Res., 367, 244, 10.1016/0006-8993(86)91598-2 Willuhn, 2003, Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioral context, Eur. J. Neurosci., 17, 1053, 10.1046/j.1460-9568.2003.02525.x Yamamoto, 1988, The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat, Eur. J. Pharmacol., 148, 195, 10.1016/0014-2999(88)90564-X Yamamoto, 1995, Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra, J. Pharmacol. Exp. Ther., 273, 1063 Yoshikawa, 1984, Rat brain preproenkephalin mRNA. cDNA cloning primary structure, and distribution in the central nervous system, J. Biol. Chem., 259, 14301, 10.1016/S0021-9258(18)89893-3